Benzinga | Feb 26, 2021 06:03AM EST

Mersana Therapeutics Q4 EPS $(0.42) Misses $(0.32) Estimate, Sales $10.00K Miss $170.00K Estimate

Mersana Therapeutics (NASDAQ:MRSN) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.32) by 31.25 percent. This is a 23.53 percent decrease over losses of $(0.34) per share from the same period last year. The company reported quarterly sales of $10.00 thousand which missed the analyst consensus estimate of $170.00 thousand by 94.12 percent. This is a 76.19 percent decrease over sales of $42.00 thousand the same period last year.